The absence of Carbohydrate Response Element Binding Protein (ChREBP) results in reduction of triglycerides, lowering of resistance to insulin and prevention of normally obese mice from becoming fat. This study on mice was conducted by researchers at the University of Texas, Katsumi Iizuka, Bonnie Miller and Kosaku Uyeda of the UT Southwestern Medical Center, in Dallas.
They discovered the important role played by ChREBP in metabolism and appetite control. Uyeda said, 'These results show the important role ChREBP plays in metabolism and appetite control in mice and, presumably, humans. Ultimately we hope to develop drugs to inactivate and control ChREBP to overcome these two major health problems of obesity and diabetes.'
Advertisement
Uyeda added, 'We found that the group (that did not have ChREBP) did not become obese, had lower blood glucose levels than the obese group and were less insulin resistant. We also were very surprised to find that these mice ate much less than the obese mice of the second group.'
He said, 'These results show the important role ChREBP plays in metabolism and appetite control in mice and, presumably, humans. Ultimately we hope to develop drugs to inactivate and control ChREBP to overcome these two major health problems of obesity and diabetes.'
Source: Medindia
GAY
Source: Medindia
GAY
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Obesity News
KDS2010 drug was found to regulate astrocytes in brain which enhances fat metabolism resulting in weight loss without the need for dietary restrictions.
In obese patients undergoing weight-loss surgery, higher blood levels of inflammation are associated with poor weight loss post-surgery.
Coconut oil supplements over a long period of time may have a major impact on the metabolic changes in diet that can lead to obesity.
Intake of anti-obesity drug liraglutide, resulted in better brain activity and in-turn finer associative learning in obese individuals.
Anti-obesity potential of a tropical plant emerges as a promising solution to address the global surge in obesity-related lifestyle diseases.
